IBDEI14B ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19725,2)
 ;;=^336841
 ;;^UTILITY(U,$J,358.3,19726,0)
 ;;=V18.0^^105^1235^15
 ;;^UTILITY(U,$J,358.3,19726,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19726,1,4,0)
 ;;=4^V18.0
 ;;^UTILITY(U,$J,358.3,19726,1,5,0)
 ;;=5^Family h/o Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,19726,2)
 ;;=^295311
 ;;^UTILITY(U,$J,358.3,19727,0)
 ;;=V16.0^^105^1235^7
 ;;^UTILITY(U,$J,358.3,19727,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19727,1,4,0)
 ;;=4^V16.0
 ;;^UTILITY(U,$J,358.3,19727,1,5,0)
 ;;=5^Family h/o Cancer of GI Tract
 ;;^UTILITY(U,$J,358.3,19727,2)
 ;;=^295292
 ;;^UTILITY(U,$J,358.3,19728,0)
 ;;=V16.1^^105^1235^8
 ;;^UTILITY(U,$J,358.3,19728,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19728,1,4,0)
 ;;=4^V16.1
 ;;^UTILITY(U,$J,358.3,19728,1,5,0)
 ;;=5^Family h/o Cancer of Lung
 ;;^UTILITY(U,$J,358.3,19728,2)
 ;;=^295293
 ;;^UTILITY(U,$J,358.3,19729,0)
 ;;=V19.6^^105^1235^1
 ;;^UTILITY(U,$J,358.3,19729,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19729,1,4,0)
 ;;=4^V19.6
 ;;^UTILITY(U,$J,358.3,19729,1,5,0)
 ;;=5^Family h/o Allergic Disorder
 ;;^UTILITY(U,$J,358.3,19729,2)
 ;;=^295326
 ;;^UTILITY(U,$J,358.3,19730,0)
 ;;=V18.2^^105^1235^2
 ;;^UTILITY(U,$J,358.3,19730,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19730,1,4,0)
 ;;=4^V18.2
 ;;^UTILITY(U,$J,358.3,19730,1,5,0)
 ;;=5^Family h/o Anemia
 ;;^UTILITY(U,$J,358.3,19730,2)
 ;;=^295313
 ;;^UTILITY(U,$J,358.3,19731,0)
 ;;=V17.5^^105^1235^4
 ;;^UTILITY(U,$J,358.3,19731,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19731,1,4,0)
 ;;=4^V17.5
 ;;^UTILITY(U,$J,358.3,19731,1,5,0)
 ;;=5^Family h/o Asthma
 ;;^UTILITY(U,$J,358.3,19731,2)
 ;;=^295307
 ;;^UTILITY(U,$J,358.3,19732,0)
 ;;=V17.7^^105^1235^3
 ;;^UTILITY(U,$J,358.3,19732,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19732,1,4,0)
 ;;=4^V17.7
 ;;^UTILITY(U,$J,358.3,19732,1,5,0)
 ;;=5^Family h/o Arthritis
 ;;^UTILITY(U,$J,358.3,19732,2)
 ;;=^295309
 ;;^UTILITY(U,$J,358.3,19733,0)
 ;;=V19.0^^105^1235^5
 ;;^UTILITY(U,$J,358.3,19733,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19733,1,4,0)
 ;;=4^V19.0
 ;;^UTILITY(U,$J,358.3,19733,1,5,0)
 ;;=5^Family h/o Blindness
 ;;^UTILITY(U,$J,358.3,19733,2)
 ;;=^295320
 ;;^UTILITY(U,$J,358.3,19734,0)
 ;;=V16.3^^105^1235^6
 ;;^UTILITY(U,$J,358.3,19734,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19734,1,4,0)
 ;;=4^V16.3
 ;;^UTILITY(U,$J,358.3,19734,1,5,0)
 ;;=5^Family h/o Cancer of Breast
 ;;^UTILITY(U,$J,358.3,19734,2)
 ;;=^295295
 ;;^UTILITY(U,$J,358.3,19735,0)
 ;;=V16.41^^105^1235^9
 ;;^UTILITY(U,$J,358.3,19735,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19735,1,4,0)
 ;;=4^V16.41
 ;;^UTILITY(U,$J,358.3,19735,1,5,0)
 ;;=5^Family h/o Cancer of Ovary
 ;;^UTILITY(U,$J,358.3,19735,2)
 ;;=^317951
 ;;^UTILITY(U,$J,358.3,19736,0)
 ;;=V16.42^^105^1235^10
 ;;^UTILITY(U,$J,358.3,19736,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19736,1,4,0)
 ;;=4^V16.42
 ;;^UTILITY(U,$J,358.3,19736,1,5,0)
 ;;=5^Family h/o Cancer of Prostate
 ;;^UTILITY(U,$J,358.3,19736,2)
 ;;=^317952
 ;;^UTILITY(U,$J,358.3,19737,0)
 ;;=V16.43^^105^1235^11
 ;;^UTILITY(U,$J,358.3,19737,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19737,1,4,0)
 ;;=4^V16.43
 ;;^UTILITY(U,$J,358.3,19737,1,5,0)
 ;;=5^Family h/o Cancer of Testis
 ;;^UTILITY(U,$J,358.3,19737,2)
 ;;=^317953
 ;;^UTILITY(U,$J,358.3,19738,0)
 ;;=V19.5^^105^1235^13
 ;;^UTILITY(U,$J,358.3,19738,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,19738,1,4,0)
 ;;=4^V19.5
 ;;^UTILITY(U,$J,358.3,19738,1,5,0)
 ;;=5^Family h/o Congenital Anomalies
 ;;^UTILITY(U,$J,358.3,19738,2)
 ;;=^295325
 ;;^UTILITY(U,$J,358.3,19739,0)
 ;;=V19.2^^105^1235^14
 ;;^UTILITY(U,$J,358.3,19739,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI14B
